Rykina-Tameeva Nadya, Samra Jaswinder S, Sahni Sumit, Mittal Anubhav
Faculty of Medicine and Health, University of Sydney, Camperdown, NSW 2050, Australia.
Kolling Institute of Medical Research, University of Sydney, St Leonards, NSW 2065, Australia.
Cancers (Basel). 2023 Dec 15;15(24):5865. doi: 10.3390/cancers15245865.
Clinically relevant postoperative pancreatic fistula (CR-POPF) is the leading cause of morbidity and mortality after pancreatic surgery. Post-pancreatectomy acute pancreatitis (PPAP) has been increasingly understood as a precursor and exacerbator of CR-POPF. No longer believed to be the consequence of surgical technique, the solution to preventing CR-POPF may lie instead in non-surgical, mainly pharmacological interventions. Five databases were searched, identifying eight pharmacological preventative strategies, including neoadjuvant therapy, somatostatin and its analogues, antibiotics, analgesia, corticosteroids, protease inhibitors, miscellaneous interventions with few reports, and combination strategies. Two further non-surgical interventions studied were nutrition and fluids. New potential interventions were also identified from related surgical and experimental contexts. Given the varied efficacy reported for these interventions, numerous opportunities for clarifying this heterogeneity remain. By reducing CR-POPF, patients may avoid morbid sequelae, experience shorter hospital stays, and ensure timely delivery of adjuvant therapy, overall aiding survival where prognosis, particularly in pancreatic cancer patients, is poor.
临床相关的术后胰瘘(CR-POPF)是胰腺手术后发病和死亡的主要原因。胰十二指肠切除术后急性胰腺炎(PPAP)越来越被认为是CR-POPF的先兆和加重因素。预防CR-POPF的解决方案不再被认为是手术技术的结果,而可能在于非手术干预,主要是药物干预。检索了五个数据库,确定了八种药物预防策略,包括新辅助治疗、生长抑素及其类似物、抗生素、镇痛、皮质类固醇、蛋白酶抑制剂、报告较少的其他干预措施以及联合策略。另外两项研究的非手术干预措施是营养和液体。还从相关手术和实验背景中确定了新的潜在干预措施。鉴于这些干预措施的疗效各不相同,仍有许多机会来阐明这种异质性。通过减少CR-POPF,患者可以避免出现病态后遗症,缩短住院时间,并确保辅助治疗的及时进行,总体上有助于改善预后较差患者(尤其是胰腺癌患者)的生存情况。